MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, VRNA made $103,138K in revenue. $11,921K in net income. Net profit margin of 11.56%.

Income Overview

Revenue
$103,138K
Net Income
$11,921K
Net Profit Margin
11.56%
EPS
$0.02
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Product And Service Other

Income Statement
2025-06-30
2024-12-31
2024-09-30
Total revenue, net
103,138 25,389* 5,624
Research and development
12,950 12,918* 10,552
Cost of sales
4,756 953* 543
Selling, general and administrative
72,127 44,144* 35,196
Total operating expenses
89,833 58,015* 46,291
Operating income/(loss)
13,305 -32,626* -40,667
Foreign exchange gain(loss)
--1,475
Research and development tax credit
0 -1,236* 1,612
Interest expense
--9,882
Interest income
4,302 1,012* 4,750
Interest expense
6,822 1,188* -
Loss on extinguishment of debt
0 -913* -
Foreign exchange gain/(loss)
1,097 -42* -
Total other (expense)/income, net
-1,423 -2,367* -2,045
Income/(loss) before income taxes
11,882 -34,993* -42,712
Income tax benefit/(expense)
-39 9,539* 250
Net income/(loss)
11,921 -44,532 -42,962
Basic EPS
0.02 -0.068 -0.07
Diluted EPS
0.02 -0.068 -0.07
Basic Average Shares
685,155,000 652,677,164 651,944,000
Diluted Average Shares
727,223,000 652,677,164 651,944,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product$102,939K Product And ServiceOther$199K Total revenue, net$103,138K Operating income/(loss)$13,305K Total operatingexpenses$89,833K Income/(loss) before incometaxes$11,882K Income taxbenefit/(expense)-$39K Total other(expense)/income, net-$1,423K Interest income$4,302K Foreign exchangegain/(loss)$1,097K Selling, general andadministrative$72,127K Research and development$12,950K Cost of sales$4,756K Net income/(loss)$11,921K Interest expense$6,822K

Verona Pharma plc (VRNA)

Verona Pharma plc (VRNA)